A Study of Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Participants Who Have Experienced CINV(Chemotherapy-Induced Nausea and Vomiting) During the Previous Cycle of Low Emetogenic Chemotherapy (LEC)

Clinical trial NCT01054456 · COMPLETED

Trial details

NCT number: NCT01054456
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Patients With Confirmed Malignant Disease to Receive Low Emetogenic Chemotherapy (LEC) or Who Experienced at Least Nausea and Vomiting During Last Cycle of LEC

Start date: 2009-10-27
Primary completion: 2010-12-08
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.